Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
212.45M | 152.55M | 119.03M | 92.88M | 37.29M | Gross Profit |
242.40M | 133.65M | 100.37M | 74.88M | 28.39M | EBIT |
-16.14M | -14.49M | -39.69M | -54.30M | -57.82M | EBITDA |
-6.65M | -8.21M | -39.61M | -53.95M | -57.48M | Net Income Common Stockholders |
-18.88M | -20.60M | -45.02M | -61.32M | -60.52M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
35.00M | 33.15M | 3.96M | 41.33M | 9.18M | Total Assets |
72.46M | 58.48M | 25.67M | 49.92M | 13.05M | Total Debt |
25.10M | 18.93M | 4.13M | 1.85M | 1.06M | Net Debt |
-9.90M | -14.21M | 168.52K | -39.48M | -8.11M | Total Liabilities |
76.51M | 52.91M | 32.97M | 24.10M | 13.88M | Stockholders Equity |
-5.49T | 3.51M | -6.83M | 26.85M | 1.35M |
Cash Flow | Free Cash Flow | |||
5.98M | 86.95K | -35.83M | -36.49M | -12.53M | Operating Cash Flow |
17.51M | 8.82M | -22.94M | -33.09M | -12.13M | Investing Cash Flow |
-11.54M | -8.73M | -13.91M | -3.40M | -798.14K | Financing Cash Flow |
-4.12M | 29.10M | -528.20K | 68.64M | 21.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $524.47M | ― | 301.60% | ― | 43.07% | 55.40% | |
57 Neutral | $225.75M | ― | 322.49% | ― | -30.66% | 36.48% | |
57 Neutral | $9.69B | ― | -56.13% | 8.92% | 5.08% | 4.43% | |
53 Neutral | $77.87M | 353.27 | 0.36% | ― | -10.82% | ― | |
53 Neutral | $5.19B | 3.33 | -45.04% | 2.83% | 17.58% | -0.66% | |
52 Neutral | $207.20M | 25.27 | -7.77% | ― | -46.95% | -237.44% | |
47 Neutral | $252.46M | ― | -30.47% | ― | ― | -22.66% |
On April 25, 2025, LifeMD acquired key assets from Optimal Human Health MD, a nationwide women’s health virtual care provider, marking its entry into the women’s health market. This strategic acquisition aims to address the significant unmet need for accessible, personalized, and high-quality care in women’s health, particularly in areas like menopause and osteoporosis. The acquisition aligns with LifeMD’s strategy to scale high-demand specialty care verticals, leveraging its national provider network and partnerships to deliver comprehensive virtual-first women’s health services.